Both INPP4B and PTEN display modest rates of copy number alterations (CNAs) in primary tumors and a significant loss of expression in metastatic cancers, with the corresponding increase in PI3K/Akt signaling in all metastases [4]. This evidence concerns the gene INPP4B and metastatic malignant neoplasm.